About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials | 949 Studies Recruiting

Clinical TrialsBrain Cancer

Brain Cancer Clinical Trials

Browse 949 clinical trials for brain cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 949 trials

CompletedStudy of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain TumorThis is a multicenter study evaluating the safety and tolerability of Toca 511 administered intravenously to patients with recurrent or progressive Grade III or Grade IV Gliomas…NCT01985256·Irvine, California and 5 others TerminatedEfficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary GlioblastomaIn this multinational Phase III study the efficacy and safety of 10 µM AP 12009 is compared to standard chemotherapy (temozolomide or BCNU or CCNU) in adult patients with…NCT00761280·Edison, New Jersey and 67 others

Related Searches

glioblastomatrials gliomatrials brain tumortrials

Data from ClinicalTrials.govTerms

TerminatedNelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma MultiformeRATIONALE: Nelfinavir mesylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00915694·Philadelphia, Pennsylvania

TerminatedBevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First RecurrenceThis is a phase 1b study for safety and tolerability of bevacizumab(Avastin)administered into the tumor resection cavity in subjects with Glioblastoma Multiforme (GBM) at first…NCT01526837·White Plains, New York

CompletedPh. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + TemozolomideObjective: To determine activity of combo of Irinotecan + Temozolomide To further characterize any toxicity associated w combo of Irinotecan + TemozolomideNCT00616005·Durham, North Carolina

RecruitingControl Cohort CTRL COHAutoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose.NCT05370079·Bron

RecruitingStupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced SpreadThe goal of this clinical trial is to learn if a combined treatment approach can treat glioblastoma (GBM) with ventricular invasion or meningeal metastasis in adults.NCT07193654·Hangzhou, Zhejiang

CompletedStem Cell Transplant for High Risk Central Nervous System (CNS) TumorsThe primary goal of this study is to determine if a stem cell transplant in patients with newly diagnosed high risk CNS tumors (glioblastoma multiforme \[GBM\], high grade…NCT00179803·Chicago, Illinois

CompletedGossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy, such as gossypol and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT00390403·Birmingham, Alabama and 7 others

CompletedAlanosine in Treating Patients With Progressive or Recurrent Malignant GliomasRATIONALE: Drugs used in chemotherapy, such as alanosine, use different ways to stop tumor cells from dividing so they stop growing or die.NCT00075894·Tampa, Florida and 4 others

CompletedBrachytherapy in Treating Patients With Recurrent Malignant GliomaRATIONALE: Brachytherapy uses radioactive material to kill cancer cells remaining after surgery.NCT00045474·Birmingham, Alabama and 8 others

CompletedOral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic AstrocytomaThis study will offer a safe treatment for patients with relapsing recurring glioblastoma (GBM) or anaplastic astrocytoma (AA).NCT00301418·New York, New York

CompletedCCI-779 in Treating Patients With Recurrent Glioblastoma MultiformePhase II trial to study the effectiveness of CCI-779 in treating patients who have recurrent glioblastoma multiforme.NCT00016328·Rochester, Minnesota

Active not recruitingPilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain TumorsThis study will look at the effects, good and/or bad, of treating primary brain cancers with diet therapy using an energy restricted ketogenic diet (ERKD) that uses food.NCT01535911·East Lansing, Michigan

CompletedBevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant GliomaThe purpose of this study is to test the safety of a new plan for treating glioblastoma.NCT00782756·Basking Ridge, New Jersey and 2 others

CompletedTemozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00112502·Fort Smith, Arkansas and 11 others

CompletedTemozolomide in Treating Patients With Recurrent High-Grade GliomaRATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00619112·San Francisco, California

Not yet recruitingDLL3 CAR-T Therapy Targeting Brain TumorsThe purpose of this study is to assess the feasibility, safety and efficacy of Delta-like ligand 3 (DLL3)-specific CAR-T cell therapy in patients with DLL3 positive brain tumors…NCT07180927·Shenzhen, Guangdong

CompletedBrain Tumor Intraoperative Ultrasound DatabasePredicting the survival of patients diagnosed with glioblastoma (GBM) is essential to guide surgical strategy and subsequent adjuvant therapies.NCT05062772·Boston, Massachusetts and 5 others

CompletedBrain Imaging to Predict Toxicity in Elderly Patients After RadiotherapyThe investigators' aim with the BRITER study is to produce a way of predicting who might be more or less likely to suffer side effects from radiotherapy prior to starting…NCT05671016·Brighton, Sussex

PreviousPage 10 of 48Next